Mercks

A Covid drug that has just been approved in virus-stricken China causes the coronavirus to mutate in new ways, a study warns. US and UK researchers identified the new mutations in viral samples taken from dozens of patients given Merck's…

Stefanie Joho, 27, stands for a portrait at the home of a friend in Penn Valley, PA on Tuesday, May 9, 2017. Joho, who was diagnosed with colon cancer at 22 years old, has been in remission since February 2016, thanks to an immunotherapy…

Dr. Dean Li, a Merck executive, said on Thursday that preliminary laboratory studies suggested that the drug was equally effective against Omicron as it was against earlier versions of the virus. The company and independent researchers have…

The decision to grant an emergency use authorisation came a day after the agency gave a green light to a similar but more effective pill developed by Pfizer.…

The Food and Drug Administration on Thursday authorized a second antiviral pill for Covid but said it should not be a preferred treatment.The F.D.A. cleared the pill, developed by Merck and known as molnupiravir, for adults who are…

A new Covid-19 pill from Merck has raised hopes that it could transform the landscape of treatment options for Americans at high risk of severe disease at a time when the Omicron variant of the coronavirus is driving a surge of cases in…

In a clinical trial, molnupiravir was found to reduce by 30 percent the risk of hospitalization or death when given to high-risk, unvaccinated volunteers within five days after they started showing symptoms. It appears to be substantially…

A U.S. Food and Drug Administration (FDA) advisory committee recommended emergency use authorization of Merck & Co's experimental pill to treat mild-to-moderate COVID-19 patients on Tuesday.The drug, called molnupiravir, stops the virus…

A Food and Drug Administration advisory panel on Tuesday narrowly endorsed the uPse of Merck and Ridgeback Biotherapeutics' oral Covid treatment pill, despite questions about the drug's effectiveness, safety and whether it would help the…

As the world reels from the emergence of the Omicron variant of the coronavirus, a panel of advisers to the Food and Drug Administration will meet on Tuesday to discuss an antiviral pill from Merck, the first in a new class of treatments…